TY - JOUR
T1 - Fatigue in patients with Behcet's syndrome
T2 - Relationship with quality of life, depression, anxiety, disability and disease activity
AU - Ilhan, Birkan
AU - Can, Meryem
AU - Alibaz-Oner, Fatma
AU - Yilmaz-Oner, Sibel
AU - Polat-Korkmaz, Ozge
AU - Ozen, Gulsen
AU - Mumcu, Gonca
AU - Maradit Kremers, Hilal D
AU - Direskeneli, Haner
PY - 2016
Y1 - 2016
N2 - Objectives: Fatigue is a common symptom of chronic inflammatory diseases. The objective of this study was to investigate fatigue in patients with Behcet's syndrome (BS) and to examine the relationship between fatigue and disease activity, quality of life, anxiety and depression. Methods: This is a cross-sectional study of 123 BS patients and 71 healthy controls in Turkey. All subjects completed the Multidimensional Assessment of Fatigue (MAF) questionnaire, Short form-36 (SF-36), Hospital Anxiety and Depression (HADS) scale and Health Assessment Questionnaire (HAQ). Disease activity among BS patients was assessed using the Behcet Syndrome Activity Scale (BSAS) and the physician's global assessment (PGA). Results: BS patients had significantly higher MAF, HADS-depression (HADS-D) and HADS-anxiety (HADS-A) scores than the healthy controls (P <0.001). Both the physical and mental components of the SF-36 scale were impaired in BS patients (P = 0.0001). BS patients with active disease, depression and anxiety had significantly higher MAF scores compared to BS patients without active disease, depression and anxiety (P = 0.0001). MAF scores showed positive correlations with HADS-A, HADS-D, HAQ scores and negative correlations with SF-36 mental and physical components. In regression analyses, depression, anxiety and physical dysfunction were significantly associated with fatigue, after adjusting for age, sex, SF-36 physical and mental scores, HAQ, HADS-A, HADS-D and BSAS scores (P <0.05). Decreases in SF-36 physical and mental scores were significant predictive factors for high MAF score in healthy controls (P <0.05). Conclusions: Fatigue is common in clinically active BS patients compared with healthy controls and inactive BS patients. Depression, anxiety and physical dysfunction were significantly associated with fatigue.
AB - Objectives: Fatigue is a common symptom of chronic inflammatory diseases. The objective of this study was to investigate fatigue in patients with Behcet's syndrome (BS) and to examine the relationship between fatigue and disease activity, quality of life, anxiety and depression. Methods: This is a cross-sectional study of 123 BS patients and 71 healthy controls in Turkey. All subjects completed the Multidimensional Assessment of Fatigue (MAF) questionnaire, Short form-36 (SF-36), Hospital Anxiety and Depression (HADS) scale and Health Assessment Questionnaire (HAQ). Disease activity among BS patients was assessed using the Behcet Syndrome Activity Scale (BSAS) and the physician's global assessment (PGA). Results: BS patients had significantly higher MAF, HADS-depression (HADS-D) and HADS-anxiety (HADS-A) scores than the healthy controls (P <0.001). Both the physical and mental components of the SF-36 scale were impaired in BS patients (P = 0.0001). BS patients with active disease, depression and anxiety had significantly higher MAF scores compared to BS patients without active disease, depression and anxiety (P = 0.0001). MAF scores showed positive correlations with HADS-A, HADS-D, HAQ scores and negative correlations with SF-36 mental and physical components. In regression analyses, depression, anxiety and physical dysfunction were significantly associated with fatigue, after adjusting for age, sex, SF-36 physical and mental scores, HAQ, HADS-A, HADS-D and BSAS scores (P <0.05). Decreases in SF-36 physical and mental scores were significant predictive factors for high MAF score in healthy controls (P <0.05). Conclusions: Fatigue is common in clinically active BS patients compared with healthy controls and inactive BS patients. Depression, anxiety and physical dysfunction were significantly associated with fatigue.
KW - Miscellaneous topics
KW - Vasculitides
UR - http://www.scopus.com/inward/record.url?scp=84959377723&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84959377723&partnerID=8YFLogxK
U2 - 10.1111/1756-185X.12839
DO - 10.1111/1756-185X.12839
M3 - Article
C2 - 26913703
AN - SCOPUS:84959377723
SN - 1756-1841
JO - International Journal of Rheumatic Diseases
JF - International Journal of Rheumatic Diseases
ER -